Spiegelman Daniel K - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	3	1	27	-1	-2	-0	4	4	14	3
S	%wins				56	74	59	39	62	53	57

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
6/2/23 18:15	6/2/23	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S	-199	23.01	0	-9	-18	40	D
6/6/22 19:20	6/6/22	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S	-124	19.25	0	-6	-16	34	D
6/17/21 17:41	6/17/21	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S	-96	30.52	0	-3	-12	23	D
6/1/21 19:15	5/28/21	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S	-207	28.99	0	-7	-35	13	D
4/3/19 13:17	4/1/19	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-1,199	89.00	0	-13	-22	48	D
3/29/19 18:19	3/27/19	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-9	90.00	0	0	0	61	D
6/26/18 20:31	6/22/18	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-990	99.00	0	-10	-16	51	D
4/25/18 20:37	4/23/18	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-908	82.15	0	-11	-15	63	D
10/13/17 20:43	5/27/15	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.ad	-4,430	130.00	0	-34	-31	76	D
3/17/17 18:30	3/16/17	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-183	91.96	33	-2	-12	14	D	-29	13	-5	9	3	4	2	-2	-1	-4	0
3/8/17 19:28	3/6/17	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-215	93.32	33	-2	-10	21	D	-22	1	-7	9	6	-2	2	-4	1	1	-5
3/2/17 18:20	2/28/17	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.dm	-3,293	94.07	33	-35	-58	25	D	-13	7	-2	6	8	3	4	7	1	-3	-5
1/10/17 16:50	1/9/17	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-450	90.00	33	-5	-22	18	D	-3	-5	3	-3	2	7	8	5	-5	-6	1	-2
11/14/16 14:02	11/9/16	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-1,812	90.61	33	-20	-46	23	D	5	-14	6	-2	-3	11	13	10	2	-3	-9	0
8/3/16 10:19	8/1/16	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-397	99.33	33	-4	-9	43	D	60	-33	38	16	22	14	6	1	2	-4	-5	-19	-11
6/8/16 20:39	6/6/16	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-147	89.14	33	-2	-3	47	D	38	-31	-13	0	-4	2	-2	-7	-1	-4	5	13	-2
6/8/16 17:22	6/7/16	RLYP	Relypsa Inc		Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	D		S	-20	19.31	33	-1	-45	1	D	-21	-46	-34	43	5	32	17	-7	-2	1	2
6/2/16 18:21	5/31/16	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-1,873	89.88	33	-21	-29	50	D	51	-30	-8	0	-2	6	1	0	-2	-8	-16	4	-5
5/25/16 14:57	5/23/16	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-328	87.07	33	-4	-6	59	D	56	-31	-9	15	-1	7	6	4	1	-1	-5	13	-1
3/2/16 20:37	3/2/16	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-398	86.12	33	-5	-9	50	D	8	-19	-34	-9	10	34	13	15	2	-2	-6	3	9	7
11/18/15 16:03	11/16/15	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-2,086	104.30	33	-20	-41	28	D	55	29	-16	-21	5	-6	-7	0	-4	-9	-7	-28	-21	-17
6/8/15 18:09	6/5/15	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-202	122.30	33	-2	-6	28	D	115	96	36	9	3	1	-4	0	-3	-2	13	2	-24	-28
6/3/15 20:27	5/29/15	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.m	-689	124.73	33	-6	-15	32	D	98	114	38	14	2	2	-2	-3	-3	-3	10	4	-23	-29
5/28/15 17:10	5/18/15	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-4,430	130.00	33	-34	-45	42	D	101	127	51	21	7	8	6	2	-1	-3	6	-5	-23	-30
5/19/15 19:25	5/18/15	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-257	124.77	33	-2	-3	76	D	95	119	43	24	4	9	5	4	2	2	-1	11	-14	-32
3/4/15 19:48	3/2/15	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-1,659	107.00	33	-16	-18	69	D	82	36	52	21	9	14	1	0	3	3	10	13	18	-21
2/10/15 12:57	3/5/14	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.m	-3	70.61	33	0	0	69	D	72	40	47	12	3	-5	-6	0	1	8	22	29	45	-31
10/8/14 16:49	2/20/13	ONTY	Oncothyreon Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Spiegelman Daniel K	WA	D		S.m	-31	1.91	2	-16	-44	21	D	-61	3	-32	-25	-14	2	-3	-4	-9	-7	-14	-16	-15	43
9/3/14 18:48	9/2/14	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-1,117	69.83	33	-16	-19	69	D	84	8	-13	14	17	9	1	-1	-3	-3	0	28	56	77
8/4/14 16:35	8/1/14	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-138	61.76	33	-2	-3	69	D	57	-4	-10	7	-6	5	0	2	1	0	10	29	50	134
7/3/14 15:24	7/2/14	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-143	64.00	33	-2	-3	71	D	71	8	-9	-6	14	4	0	2	0	-8	-4	10	41	113
3/5/14 16:40	3/3/14	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-643	80.32	33	-8	-11	64	D	126	34	23	15	9	14	-1	-3	-3	-2	-14	-22	-11	38
12/4/13 16:15	12/2/13	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-631	70.14	33	-9	-19	38	D	102	44	21	1	4	13	-1	-1	-1	-1	-1	10	-10	30
9/5/13 18:51	9/4/13	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-621	69.00	33	-9	-19	38	D	135	85	13	20	10	5	7	5	3	1	4	-1	9	-4
7/2/13 17:29	7/1/13	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S	-243	59.78	33	-4	-10	38	D	126	57	24	-6	-5	1	8	4	-1	0	8	21	16	7
5/3/13 14:41	5/1/13	BMRN	Biomarin Pharmaceutical Inc	DE	Health	Drug	Pharmaceutical Preparations	Spiegelman Daniel K	CA	O	EVP,CFO	S.d	-1,804	64.42	33	-28	-46	33	D	145	90	69	20	10	2	1	2	1	1	-9	-2	-3	-12
4/3/09 14:15	4/2/09	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S.d	-2,808	19.91	0	-141	-64	80	D
12/21/07 15:31	12/21/07	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S	-60	10.00	0	-6	-38	10	D
12/11/07 16:16	12/10/07	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S	-80	10.03	0	-8	-39	13	D
1/18/07 18:47	1/17/07	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S	-98	13.93	0	-7	-48	8	D
12/13/06 17:54	12/12/06	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S.d	-39	12.92	0	-3	-47	3	D
11/4/05 18:05	11/3/05	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S.d	-668	25.21	0	-27	-89	3	D
8/30/05 13:32	8/26/05	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S	-564	26.24	0	-22	-48	24	M
12/20/04 14:09	12/16/04	CVTX	Cv Therapeutics Inc	DE	Health	BioPrd	Biological Products, (No Diag	Spiegelman Daniel K	CA	O	SVP,CFO	S.d	-179	23.86	0	-8	-15	42	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y